Stock Scorecard
Stock Summary for Alector Inc (ALEC) - $1.90 as of 1/15/2026 6:26:00 PM EST
Total Score
12 out of 30
Safety Score
19 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ALEC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ALEC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ALEC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ALEC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ALEC (19 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ALEC
Financial Details for ALEC
Company Overview |
|
|---|---|
| Ticker | ALEC |
| Company Name | Alector Inc |
| Country | USA |
| Description | Alector, Inc. (ALEC) is a leading clinical-stage biopharmaceutical firm focused on developing innovative therapies for neurodegenerative diseases, specifically targeting conditions such as Alzheimer's disease and frontotemporal dementia. Employing its proprietary immuno-neurology platform, Alector seeks to harness the power of the immune system to enhance neuronal health and function, thereby positioning itself as a key player in the rapidly evolving field of neurology. Headquartered in South San Francisco, the company features a robust pipeline of distinctive product candidates, which hold the potential to transform existing treatment paradigms and significantly elevate patient care in areas with substantial unmet medical needs. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/25/2026 |
Stock Price History |
|
| Last Day Price | 1.90 |
| Price 4 Years Ago | 9.23 |
| Last Day Price Updated | 1/15/2026 6:26:00 PM EST |
| Last Day Volume | 1,286,891 |
| Average Daily Volume | 1,457,343 |
| 52-Week High | 3.40 |
| 52-Week Low | 0.87 |
| Last Price to 52 Week Low | 118.39% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 19.60 |
| Sector PE | 43.35 |
| 5-Year Average PE | -10.43 |
| Free Cash Flow Ratio | 2.71 |
| Industry Free Cash Flow Ratio | 12.80 |
| Sector Free Cash Flow Ratio | 31.05 |
| Current Ratio Most Recent Quarter | 3.76 |
| Total Cash Per Share | 0.70 |
| Book Value Per Share Most Recent Quarter | 0.54 |
| Price to Book Ratio | 3.50 |
| Industry Price to Book Ratio | 53.14 |
| Sector Price to Book Ratio | 52.10 |
| Price to Sales Ratio Twelve Trailing Months | 2.93 |
| Industry Price to Sales Ratio Twelve Trailing Months | 19.78 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.91 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 109,151,000 |
| Market Capitalization | 207,386,900 |
| Institutional Ownership | 81.83% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -86.30% |
| Annual Earnings Growth | 8.70% |
| Reported EPS 12 Trailing Months | -1.06 |
| Reported EPS Past Year | -1.05 |
| Reported EPS Prior Year | -1.23 |
| Net Income Twelve Trailing Months | -107,736,000 |
| Net Income Past Year | -119,049,000 |
| Net Income Prior Year | -130,391,000 |
| Quarterly Revenue Growth YOY | -78.80% |
| 5-Year Revenue Growth | 36.50% |
| Operating Margin Twelve Trailing Months | -1,154.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 76,503,000 |
| Total Cash Past Year | 33,021,000 |
| Total Cash Prior Year | 74,555,000 |
| Net Cash Position Most Recent Quarter | 66,892,000 |
| Net Cash Position Past Year | 23,632,000 |
| Long Term Debt Past Year | 9,389,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 9,611,000 |
| Equity to Debt Ratio Past Year | 0.93 |
| Equity to Debt Ratio Most Recent Quarter | 0.86 |
| Total Stockholder Equity Past Year | 126,800,000 |
| Total Stockholder Equity Prior Year | 134,158,000 |
| Total Stockholder Equity Most Recent Quarter | 57,712,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -197,582,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.81 |
| Free Cash Flow Past Year | -231,160,000 |
| Free Cash Flow Prior Year | -186,543,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.61 |
| RSI | 0.00 |
| 50-Day SMA | 1.72 |
| 150-Day SMA | 4.33 |
| 200-Day SMA | 5.73 |
System |
|
| Modified | 1/15/2026 4:55:12 PM EST |